2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
What Are the Primary Drivers Supporting the Market Growth of theTremfya Market?
The increasing prevalence of autoimmune diseases is expected to propel the growth of the tremfya market going forward. Autoimmune diseases refer to conditions in which the body’s immune system mistakenly attacks its cells, tissues, or organs, perceiving them as foreign invaders. The increasing prevalence of autoimmune diseases is due to genetic predisposition, environmental triggers, lifestyle changes, increased awareness, and improved diagnostic capabilities. Tremfya is a monoclonal antibody targeting interleukin-23 (IL-23) that helps manage autoimmune diseases by modulating the immune system’s overactive response, reducing inflammation, and alleviating symptoms in conditions such as psoriasis and psoriatic arthritis. For instance, in June 2024, according to a report published by the Australian Institute of Health and Welfare, an Australian-based governmental organization, in 2022, there were 10,000 hospitalizations for rheumatoid arthritis, marking a 25% increase from 8,000 in the previous year, with a hospitalization rate of 39 per 100,000 people. Therefore, the increasing prevalence of autoimmune diseases is driving the growth of the tremfya market.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20343&type=smp
#What Growth Opportunities Will Drive the Tremfya Market’s CAGR Through 2034?
The tremfya market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to the rising prevalence of psoriasis and psoriatic arthritis, increasing focus on targeted therapies, rising healthcare investments, a growing number of specialty clinics, and increased adoption of biologics in dermatology and rheumatology.
The tremfya market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to increasing healthcare infrastructure, rising adoption of point-of-care testing, increasing investment in healthcare research, and growing focus on precision medicine. Major trends in the forecast period include advancements in treatment modalities, personalized medicine approaches, technological integration in patient monitoring, integration of artificial intelligence (AI), and advancements in injection devices.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20343
What Are the Latest Innovations Influencing theTremfya Market?
The key trend in the tremfya market is gaining regulatory approvals to expand its treatment indications, such as for moderate-to-severe Crohn’s disease, which broadens its patient base and market potential. Regulatory approvals refer to the official authorization granted by authorities such as the Food and Drug Administration (FDA) or European Medicines Agency (EMA), allowing a drug to be marketed for specific uses after demonstrating its safety, efficacy, and quality. For instance, in September 2024, Johnson & Johnson, a US-based pharmaceutical industry company, received FDA approval for TREMFYA (guselkumab) for the treatment of adults with moderately to severely active ulcerative colitis, marking it as the first dual-acting interleukin-23 inhibitor approved for this condition. The decision is based on positive results from the Phase 2b/3 QUASAR study, which showed that approximately 50% of patients achieved clinical remission after 44 weeks of treatment. TREMFYA targets interleukin-23, helping to normalize the inflammatory response in the colon.
Who Are the Major Industry Players Accelerating Growth in theTremfya Market?
Major companies operating in the tremfya market are Johnson & Johnson
Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/tremfya-global-market-report
Which Primary Segments of the Tremfya Market Are Driving Growth and Industry Transformations?
The tremfya market covered in this report is segmented –
1) By Indication: Moderate-To-Severe Plaque Psoriasis; Active PsA
2) By Formulation: Subcutaneous Injection; Intravenous Infusion
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies
4) By End User: Adult Patients; Geriatric Patients
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=20343&type=smp
Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of theTremfya Market?# Market?
North America was the largest region in the tremfy market in 2024. The regions covered in the tremfya market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Reports Similar to the Global Tremfya Market 2025, By The Business Research Company:
Inflammatory Bowel Disease Treatment Global Market Report 2025
Non-Steroidal Anti-inflammatory Drugs Global Market Report 2025
Anti-Inflammatory Therapeutics Global Market Report 2025
https://thebusinessresearchcompany.com/report/anti-inflammatory-therapeutics-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
